Tibet Pharma Investors Ask Court To Dismiss IPO Suits
By Rick Archer ( July 14, 2016, 8:07 PM EDT) -- Investors in a Tibetan pharmaceutical company that accused it of lying about its financial health ahead of a 2011 initial public offering told a New Jersey court Thursday that they had reached a $14 million settlement with the company's bankrupt underwriter last year, and that they are seeking a default judgment in their class action against the company itself....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.